News

SEC Filings

Document Details

Form
Filing Date
December 5, 2019
Document Date
December 3, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Guyer Shelly D

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com